Dow Up 0.51% Nasdaq Up 0.24%

Gilead Sciences Inc. (GILD)

-NasdaqGS
100.58 Down 0.01(0.01%) Nov 21, 4:00PM EST
|After Hours : 100.51 Down 0.07 (0.07%) Nov 21, 7:57PM EST
Prev Close:100.59
Open:102.51
Bid:N/A
Ask:100.75 x 700
1y Target Est:122.63
Beta:1.24
Earnings Date:Feb 2 - Feb 6 (Est.)
Day's Range:100.08 - 102.51
52wk Range:63.50 - 116.83
Volume:16,764,996
Avg Vol (3m):15,550,600
Market Cap:151.74B
P/E (ttm):17.92
EPS (ttm):5.61
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GILD

Comparison

Symbol% ChgMkt Cap
GILDDown 0.01%151.74B
GSKUp 0.04%111.55B
PFEUp 0.03%191.86B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):10.14
P/S (ttm):7.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.96
Quarterly EPS Est (Dec-14) :2.25
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback